among the other improvements in well-being, 33 per cent of people had higher energy levels, 23 per cent reported better sexual health, and 22 per cent said that they were more likely to be more active in their daily lives.
while this data doesn’t show causation between glp-1s and these self-reported improvements across various wellness areas, the changes that accompany their use underscore that “glp-1 adoption is already meaningful” in more ways than one.
“there’s a lot of people taking them right now and more who are interested, and the impact of glp-1s is showing up in baskets and behaviours, not just prescriptions,” said lavers-sailly.
spending habits change, showcasing opportunities for retailers
self-reported wellbeing has improved for people taking these medications, but the behaviours that have changed are marking a turning point for the food and wellness industry.
according to the survey, people on these medications are now putting their money into different spaces, with 29 per cent of people spending less at restaurants and 15 per cent of people spending less at the grocery store. when it comes to alcohol, 36 per cent are spending less in that area, while 39 per cent of respondents are shelling out less cash for sugary or sweet snacks.
“people are eating less or consuming less, and that’s fewer snacks and sweets, fewer sugary drinks, less alcohol and less takeout, so that could also have some interesting implications for consumption habits and what people want more of, given that they’re having less than that,” said lavers-sailly.
the smaller consumption habits also show that cravings are no longer controlling people as they adopt more intentional consumption, with 40 per cent of respondents reporting fewer cravings for certain foods in the survey.